| GA20427-1mg |
|
1802078-82-6 |
5(6)-TAMRA-HIV-1 tat Protein (47-57)
|
0 |
C89H138N34O18 |
|
|
|
| GA20427-005mg |
|
1802078-82-6 |
5(6)-TAMRA-HIV-1 tat Protein (47-57)
|
0 |
C89H138N34O18 |
|
|
|
| GA20426-005mg |
|
1678416-64-2 |
5(6)-FAM-(Glu¹)-Orexin A (human, mouse, rat)
|
0 |
C173H255N47O51S4 |
|
|
|
| GA20426-001mg |
|
1678416-64-2 |
5(6)-FAM-(Glu¹)-Orexin A (human, mouse, rat)
|
0 |
C173H255N47O51S4 |
|
|
|
| GA20425-5g |
|
— |
4-Piperidylformylaminomethyl resin (200-400 mesh, 0.3-0.6 mmol/g)
|
0 |
— |
|
|
|
| GA20425-1g |
|
— |
4-Piperidylformylaminomethyl resin (200-400 mesh, 0.3-0.6 mmol/g)
|
0 |
— |
|
|
|
| GA20424-5g |
|
— |
4-Piperidylacetylaminomethyl resin (200-400 mesh, 0.3-0.6 mmol/g)
|
0 |
— |
|
|
|
| GA20424-1g |
|
— |
4-Piperidylacetylaminomethyl resin (200-400 mesh, 0.3-0.6 mmol/g)
|
0 |
— |
|
|
|
| GA20423-25g |
|
3150-24-1 |
4-Nitrophenyl β-D-galactopyranoside
|
0 |
C12H15NO8 |
|
|
|
| GA20423-5g |
|
3150-24-1 |
4-Nitrophenyl β-D-galactopyranoside
|
0 |
C12H15NO8 |
|
|
|
| GA20422-100g |
|
— |
4-Methyl-benzhydrylamine resin (200-400 mesh, 0.70-1.30 mmol/g) . HCl
|
0 |
— |
|
|
|
| GA20422-25g |
|
— |
4-Methyl-benzhydrylamine resin (200-400 mesh, 0.70-1.30 mmol/g) . HCl
|
0 |
— |
|
|
|
| GA20421-100g |
|
— |
4-Methyl-benzhydrylamine resin (100-200 mesh, 0.70-1.30 mmol/g) . HCl
|
0 |
— |
|
|
|
| GA20421-25g |
|
— |
4-Methyl-benzhydrylamine resin (100-200 mesh, 0.70-1.30 mmol/g) . HCl
|
0 |
— |
|
|
|
| GA20420-1g |
|
2764-95-6 |
4-Methoxy-β-naphthylamine
|
0 |
C11H11NO |
|
|
|
| GA20420-250mg |
|
2764-95-6 |
4-Methoxy-β-naphthylamine
|
0 |
C11H11NO |
|
|
|
| GA20419-1g |
|
80307-12-6 |
4-Maleimidobutyric acid N-hydroxysuccinimide ester
|
0 |
C12H12N2O6 |
|
|
|
| GA20419-005g |
|
80307-12-6 |
4-Maleimidobutyric acid N-hydroxysuccinimide ester
|
0 |
C12H12N2O6 |
|
|
|
| GA20418-5g |
|
2482-25-9 |
|
0 |
C9H9NO4 |
|
|
|
| GA20418-1g |
|
2482-25-9 |
|
0 |
C9H9NO4 |
|
|
|
